MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-PB-20-0004428
Vincit Labs Private Limited
Vincit Labs Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹51.7 Cr
▼ 12% YoY
Net loss · FY 2025
₹14.39 Cr
Net margin -27.8%
EBITDA · FY 2025
-₹7.23 Cr
EBITDA margin -14%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10.2 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
40
Provident fund records
Directors on board
2
As per MCA filings
About Vincit Labs Private Limited
Data last updated:
Vincit Labs Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Mahima Lifesciences Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2020PTC362920. Its GSTIN is 03AAHCV3542J1ZC (Punjab).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10.2 Lakh. It is led by directors Rahul Goel and Sahil Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1C 1st Floor Big Jo’S Tower A – 8 Netaji Subhash Place Pitampura New Delhi 110034, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.7 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹14.39 Cr (net margin -27.8%) and EBITDA of -₹7.23 Cr (EBITDA margin -14%). Revenue has grown at a compounded annual rate (CAGR) of 842% over three years.
The company has about 40 employees on its provident fund (EPFO) records.
Vincit Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0004428).
Company details
CIN U24110DL2020PTC362920
Registration Number 362920
Incorporation Date 18 March 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Mahima Lifesciences Private Limited
MSME Classification Medium
Udyam Registration UDYAM-PB-20-0004428
Key People
Rahul Goel Director Sahil Goel Director Recognitions & Rankings of Vincit Labs
Contact details
Vincit Labs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1C 1st Floor Big Jo’S Tower A – 8 Netaji Subhash Place Pitampura New Delhi 110034, Delhi, India – 110034
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Vincit Labs Private Limited, buy the company report.
Comprehensive company report
Vincit Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vincit Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vincit Labs Private Limited, buy the company report.
Financials of Vincit Labs Private Limited
FY 2025 filings availableVincit Labs Private Limited reported revenue of ₹51.7 Cr (down 12% YoY) for FY 2025.
Revenue · FY 2025
₹51.7 Cr ▼ 12%
Net loss · FY 2025
₹14.39 Cr margin -27.8%
EBITDA · FY 2025
-₹7.23 Cr margin -14%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 842%
EBITDA CAGR growth
1 year
▼ 182%
3 years · compounded
▼ 247%
5 years · compounded
▼ 337%
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 842%. EBITDA fell 182% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.39 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14% | ||||
| Net Profit Margin | -27.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vincit Labs Private Limited, buy the company report.
Board of directors of Vincit Labs Private Limited
Vincit Labs has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Goel | Director | 29 Mar 2022 | 4 Years 6 Months | Current |
| Sahil Goel | Director | 29 Mar 2022 | 4 Years 6 Months | Current |
Peer comparison
Vincit Labs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Flax Laboratories Private Limited | ₹52.86 Cr (FY 2025) | 26.0% | Mahad, Maharashtra, India | |||
| Vani Pharma Labs Limited | ₹52.6 Cr (FY 2020) | 40.0% | Hyderabad, Telangana, India | |||
| Om Biomedic Private Limited | ₹52.57 Cr (FY 2024) | -6.0% | Hisar, Haryana, India | |||
| Ambe Phytoextracts Private Limited | ₹52.25 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Unilab Chemicals and Pharmaceuticals Private Limited | ₹51.94 Cr (FY 2024) | 5.0% | Mumbai, Maharashtra, India | |||
| Vincit Labs Private Limitedthis company | ₹51.7 Cr (FY 2025) | -₹14.39 Cr | -27.8% | -12.0% | 40 | New Delhi, Delhi, India |
| K. A. Malle Pharmaceuticals Limited | ₹51.47 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Ranq Remedies Private Limited | ₹51.43 Cr (FY 2025) | 5.0% | Thane, Maharashtra, India | |||
| Kreative Organics Private Limited | ₹50.74 Cr (FY 2023) | 6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Vincit Labs Private Limited, buy the company report.
Auditor
Vincit Labs Private Limited is audited by SURESH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURESH & ASSOCIATES | FY 2023 | 0003316N |
Shareholding
The shareholding of Vincit Labs Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Vincit Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vincit Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Vincit Labs Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 10 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| D S Company | |||
| an individual supplier |
To see the full MSME payment records of Vincit Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Vincit Labs Private Limited has a workforce of 40 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
40
Active EPFO establishments
1
Employee growth
110.53%
GST
Vincit Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAHCV3542J1ZC | Punjab | Active | 27 Apr 2020 |
To see the full GST registrations and return filing status of Vincit Labs Private Limited, buy the company report.
Recent activity
Vincit Labs Private Limited has 6 board changes on record since 2022: 2 appointments and 4 cessations. The latest: Rahul Goel ceased to be Additional Director on 30 Sep 2022.
AGM
Vincit Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vincit Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Rahul Goel ceased to be Additional Director.
Ceased
Sahil Goel ceased to be Additional Director.
Ceased
Pramod Mittal ceased to be Director.
Ceased
Rajeev Goel ceased to be Director.
Appointed
Rahul Goel was appointed as Director.
Appointed
Sahil Goel was appointed as Director.
Incorporation
18 Mar 2020
Vincit Labs Private Limited was registered on 18 Mar 2020 with Roc Delhi & aged 6 years 7 months as per MCA records.
Frequently asked questions
Vincit Labs is an active private limited company based in New Delhi, Delhi, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 March 2020 (6+ years old) and is registered under CIN U24110DL2020PTC362920.
Vincit Labs has 2 current directors:
- Rahul Goel - Director
- Sahil Goel - Director
The latest financial statements of Vincit Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Vincit Labs is 03AAHCV3542J1ZC, registered in Punjab.
The CIN (Corporate Identification Number) of Vincit Labs is U24110DL2020PTC362920. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vincit Labs was incorporated on 18 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vincit Labs by revenue are Flax Laboratories Private Limited, Vani Pharma Labs Limited, Om Biomedic Private Limited, Ambe Phytoextracts Private Limited, Unilab Chemicals and Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Goel ceased to be Additional Director on 30 Sep 2022. Sahil Goel ceased to be Additional Director on 30 Sep 2022. Pramod Mittal ceased to be Director on 31 Mar 2022. Vincit Labs has 6 board changes on record in total.
Yes, Vincit Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-PB-20-0004428).
Vincit Labs has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 10 overdue payments to 6 micro and small suppliers. The latest return was filed on 29 Oct 2021.
The registered office of Vincit Labs is at 1C 1st Floor Big Jo’S Tower A – 8 Netaji Subhash Place Pitampura New Delhi 110034, Delhi, India – 110034.
Vincit Labs operates in the pharma industry, in the api manufacturers segment.